ArticleJACC. Heart failure2021
Physical Activity, Subclinical Myocardial Injury, and Risk of Heart Failure Subtypes in Black Adults.
Article in JACC. Heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Journal of the American College of Cardiology · 2026Guideline
- Exercise training and high-sensitivity cardiac troponin-I in patients with heart failure with reduced ejection fraction.ESC heart failure · 2024Trial
- Association of Baseline and Longitudinal Changes in Frailty Burden and Risk of Heart Failure in Type 2 Diabetes-Findings from the Look AHEAD Trial.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022Trial
- Metabolic dysfunction and incidence of heart failure subtypes among Black individuals: The Jackson Heart Study.European journal of heart failure · 2025Article
- Diabetes, Subclinical Myocardial Injury or Stress, and Risk of Heart Failure Subtypes: The Jackson Heart Study.Diabetes care · 2025Observational
- Trajectory of C-Reactive Protein and Incident Heart Failure in Black Adults: The Jackson Heart Study.Circulation. Heart failure · 2024Article
- Carotid Intima-Media Thickness and Improved Stroke Risk Assessment in Hypertensive Black Adults.American journal of hypertension · 2024Article
- Exercise Training, Cardiac Biomarkers, and Cardiorespiratory Fitness in Type 2 Diabetes: The HART-D Study.JACC. Advances · 2023Article
- Cardiac Biomarkers and Exercise Training in People With Diabetes: When a Negative Is a Positive.JACC. Advances · 2023Article
- A retrospective study on the clinical significance of cardiac computed tomography in heart failure patients with preserved ejection fraction.Annals of translational medicine · 2022Article
- Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia.European journal of heart failure · 2022Article
- Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries.Journal of the American Heart Association · 2021Article
Corrections and comments
- Commented on by
Authors and funding
16 authors at 10 institutions in 1 country.
Funding
Abstract
objectivesThis study sought to evaluate the independent associations and interactions between high-sensitivity cardiac troponin I (hs-cTnI) and physical activity (PA) with risk of heart failure (HF) subtypes, HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF).
backgroundBlack adults are at high risk for developing HF. Physical inactivity and subclinical myocardial injury, as assessed by hs-cTnI concentration, are independent risk factors for HF.
methodsBlack adults from the Jackson Heart Study without prevalent HF who had hs-cTnI concentration and self-reported PA assessed at baseline were included. Adjusted Cox models were used to evaluate the independent and joint associations and interaction between hs-cTnI concentrations and PA with risk of HFpEF and HFrEF.
resultsAmong 3,959 participants, 25.1% had subclinical myocardial injury (hs-cTnI ≥4 and ≥6 ng/l in women and men, respectively), and 48.2% were inactive (moderate-to-vigorous PA = 0 min/week). Over 12.0 years of follow-up, 163 and 150 participants had an incident HFpEF and HFrEF event, respectively. In adjusted analysis, higher hs-cTnI concentration (per 1-U log increase) was associated with higher risk of HFpEF (hazard ratio [HR]: 1.47; 95% confidence interval [CI]: 1.25 to 1.72]) and HFrEF (HR: 1.57; 95% CI: 1.35 to 1.83]). In contrast, higher PA (per 1-U log increase) was associated with a lower risk of HFpEF (HR: 0.93; 95% CI: 0.88 to 0.99]) but not HFrEF. There was a significant interaction between hs-cTnI and PA for risk of HFpEF (p interaction = 0.04) such that inactive participants with subclinical myocardial injury were at higher risk of HFpEF but active participants were not.
conclusionsAmong Black adults with subclinical myocardial injury, higher levels of PA were associated with attenuated risk of HFpEF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.